EP2858984A1 - Inhibiteurs de la réplication de virus de la grippe - Google Patents
Inhibiteurs de la réplication de virus de la grippeInfo
- Publication number
- EP2858984A1 EP2858984A1 EP13729577.0A EP13729577A EP2858984A1 EP 2858984 A1 EP2858984 A1 EP 2858984A1 EP 13729577 A EP13729577 A EP 13729577A EP 2858984 A1 EP2858984 A1 EP 2858984A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- alkyl
- optionally substituted
- independently
- compound
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne un composé selon la formule (I) : ou son sel pharmaceutiquement acceptable, les valeurs de la formule développée étant telles que décrites ici. Une composition pharmaceutique comprend une quantité efficace dudit composé ou de son sel pharmaceutiquement acceptable, et un vecteur, un adjuvant ou un véhicule pharmaceutiquement acceptable. L'invention concerne l'utilisation du composé dans l'inhibition de la réplication de virus de la grippe dans un échantillon biologique ou un patient, et dans la réduction de la quantité de virus de la grippe dans un échantillon biologique ou un patient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261657236P | 2012-06-08 | 2012-06-08 | |
PCT/US2013/044636 WO2013184985A1 (fr) | 2012-06-08 | 2013-06-07 | Inhibiteurs de la réplication de virus de la grippe |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2858984A1 true EP2858984A1 (fr) | 2015-04-15 |
Family
ID=48628957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13729577.0A Withdrawn EP2858984A1 (fr) | 2012-06-08 | 2013-06-07 | Inhibiteurs de la réplication de virus de la grippe |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2858984A1 (fr) |
WO (1) | WO2013184985A1 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS57869B1 (sr) | 2009-06-17 | 2018-12-31 | Vertex Pharma | Inhibitori replikacije virusa gripa |
UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
SI3068782T1 (sl) | 2013-11-13 | 2018-10-30 | Vertex Pharmaceuticals Incorporated | Postopki za pripravo inhibitorjev v replikacije virusov gripe |
JP6615755B2 (ja) | 2013-11-13 | 2019-12-04 | バーテックス ファーマシューティカルズ インコーポレイテッド | インフルエンザウイルスの複製の阻害剤 |
AU2015298876B2 (en) | 2014-08-08 | 2020-02-13 | Janssen Sciences Ireland Uc | Indoles for use in influenza virus infection |
JP6857617B2 (ja) | 2015-05-13 | 2021-04-14 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | インフルエンザウイルスの複製の阻害剤 |
EP3294717B1 (fr) | 2015-05-13 | 2020-07-29 | Vertex Pharmaceuticals Inc. | Procédés de préparation d'inhibiteurs de réplication des virus de la grippe |
US20170100396A1 (en) * | 2015-10-07 | 2017-04-13 | F. Hoffmann-La Roche Ag | Pyrrolopyrazine derivatives for use in the treatment, amelioration or prevention of influenza |
CA3005514A1 (fr) | 2015-11-27 | 2017-06-01 | Janssen Sciences Ireland Uc | Indoles heterocycliques a utiliser dans une infection a virus influenza |
CA3005921A1 (fr) | 2015-12-09 | 2017-06-15 | Sunshine Lake Pharma Co., Ltd. | Derives de (pyrrolo[2,3-b]pyridine-3-yl)-pyrimidine substituee et utilisation comme inhibiteurs de la replication du virus de la grippe |
AU2017205261B2 (en) | 2016-01-07 | 2021-03-25 | Janssen Sciences Ireland Uc | Functionalized pentanoic acids for use in influenza viral infections |
WO2017125506A1 (fr) * | 2016-01-20 | 2017-07-27 | Janssen Sciences Ireland Uc | Pyrimidines à substitution aryle à utiliser dans une infection par le virus de la grippe |
WO2017133667A1 (fr) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Dérivés de pyrimidine et de pyridine et leur utilisation pour traiter ou prévenir la grippe, ou pour atténuer ses symptômes |
WO2017133665A1 (fr) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Dérivés de 6,7-diazaindazole et de 6,7-diazaindole et leur utilisation dans le traitement, l'atténuation des symptômes ou la prévention de la grippe |
WO2017133658A1 (fr) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Dérivés de 4,7-diazaindole et 4,7-diazaindazole et leur utilisation pour traiter ou prévenir la grippe, ou pour atténuer ses symptômes |
WO2017133670A1 (fr) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Dérivés de pyridine et de pyrimidine et leur utilisation dans le traitement, l'atténuation des symptômes ou la prévention de la grippe |
WO2017133657A1 (fr) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Dérivés de pyridine et de pyrimidine et leur utilisation pour traiter ou prévenir la grippe, ou pour atténuer ses symptômes |
WO2017133664A1 (fr) * | 2016-02-05 | 2017-08-10 | Savira Pharmaceuticals Gmbh | Dérivés bicycliques de pyridine et de pyrimidine et leur utilisation pour traiter ou prévenir la grippe, ou pour atténuer ses symptômes |
CN107759571B (zh) | 2016-08-16 | 2021-03-02 | 广东东阳光药业有限公司 | 流感病毒复制抑制剂及其使用方法和用途 |
US10647693B2 (en) | 2016-08-30 | 2020-05-12 | North & South Brother Pharmacy Investment Company Limited | Inhibitors of influenza virus replication, application methods and uses thereof |
CN106478460B (zh) * | 2016-09-28 | 2018-06-12 | 衢州学院 | 一种手性N-Boc-3-氨基-4-芳基-丁酸的合成方法 |
AU2017376541B2 (en) * | 2016-12-15 | 2021-08-05 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication and uses thereof |
CN108276401B (zh) | 2017-01-05 | 2020-12-22 | 广东东阳光药业有限公司 | 流感病毒复制抑制剂及其用途 |
WO2018157830A1 (fr) | 2017-03-02 | 2018-09-07 | Sunshine Lake Pharma Co., Ltd. | Inhibiteurs de réplication du virus de la grippe et leurs utilisations |
CN108727369B (zh) * | 2017-04-25 | 2023-06-09 | 广东东阳光药业有限公司 | 流感病毒复制抑制剂及其用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040235761A1 (en) | 2001-08-14 | 2004-11-25 | Yousuke Furuta | Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue |
PL2332940T3 (pl) | 2004-03-30 | 2013-03-29 | Vertex Pharma | Azaindole użyteczne jako inhibitory JAK i innych kinaz białkowych |
WO2006058074A1 (fr) * | 2004-11-22 | 2006-06-01 | Vertex Pharmaceuticals Incorporated | Pyrrolopyrazines et pyrazolopyrazines convenant inhibiteurs de proteines-kinases |
BRPI0706537A2 (pt) | 2006-01-17 | 2011-03-29 | Vertex Pharma | azaindóis úteis como inibidores de janus cinases |
CA2704266A1 (fr) | 2007-11-02 | 2009-06-11 | Vertex Pharmaceuticals Incorporated | Derives de [1h-pyrazolo[3,4-b]pyridin-4-yl]-phenyle ou -pyridin-2-yle en tant qu'inhibiteurs de la proteine kinase c-theta |
WO2010011772A2 (fr) | 2008-07-23 | 2010-01-28 | Vertex Pharmaceuticals Incorporated | Inhibiteurs de la pyrazolopyridine kinase tricyclique |
JP5631310B2 (ja) | 2008-07-23 | 2014-11-26 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | 三環式ピラゾロピリジンキナーゼ阻害剤 |
AU2009274011B2 (en) | 2008-07-23 | 2014-12-18 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridine kinase inhibitors |
RS57869B1 (sr) * | 2009-06-17 | 2018-12-31 | Vertex Pharma | Inhibitori replikacije virusa gripa |
-
2013
- 2013-06-07 WO PCT/US2013/044636 patent/WO2013184985A1/fr unknown
- 2013-06-07 EP EP13729577.0A patent/EP2858984A1/fr not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO2013184985A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013184985A1 (fr) | 2013-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10875855B2 (en) | Inhibitors of influenza viruses replication | |
US8871774B2 (en) | Inhibitors of influenza viruses replication | |
EP2858984A1 (fr) | Inhibiteurs de la réplication de virus de la grippe | |
EP2651941A1 (fr) | Inhibiteurs de réplication de virus de la grippe | |
DK3141252T3 (en) | INHIBITORS OF INFLUENZA VIRUS REPLICATION | |
US20130345218A1 (en) | Inhibitors of influenza viruses replication | |
OA19823A (en) | Inhibitors of influenza viruses replication. | |
NZ620086B2 (en) | Inhibitors of influenza viruses replication | |
NZ716783B2 (en) | Inhibitors of influenza viruses replication |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20141208 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160105 |